Ahmed Nader

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Drug Administration

Cervical Cancer Screening

Top Venues

Clinical pharmacokinetics

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed Nader, Nael M Mostafa, Farah Ali, Mohamad Shebley
Drug-Drug Interaction Studies of Elagolix with Oral and Transdermal Low-Dose Hormonal Add-Back Therapy. Clinical pharmacokinetics 60 (1) (2021)
Mohamad Shebley, Akshanth R Polepally, Ahmed Nader, Juki W Ng, Insa Winzenborg, Cheri E Klein, Peter Noertersheuser, Megan A Gibbs, Nael M Mostafa
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis. Clinical pharmacokinetics 59 (3) (2021)
Insa Winzenborg, Akshanth R Polepally, Ahmed Nader, Nael M Mostafa, Peter Noertersheuser, Juki W Ng
Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis-Associated Pain: An Application of Markov Model. CPT: pharmacometrics & systems pharmacology 9 (8) (2020)
Insa Winzenborg, Ahmed Nader, Akshanth R Polepally, Mohan Liu, Jacob Degner, Cheri E Klein, Nael M Mostafa, Peter Noertersheuser, Juki Ng
Population Pharmacokinetics of Elagolix in Healthy Women and Women with Endometriosis. Clinical pharmacokinetics 57 (10) (2019)